Research Article

Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study

Table 5

Comparison between overweight and obese patients with metabolic syndrome and overweight and obese patients without metabolic syndrome according to IDF criteria.

VariableMetabolic syndrome patients patientsWithout metabolic syndrome patients patients value

Boys (%)6 (24%)29 (67.4%)0.001
Age (years)11 (6)8 (6)0.005
Weight percentile97th (5)97th (4)0.47
Waist percentile95th (4)95th (4)0.074
Midarm circumference centile95th (9)95th (7)0.89
BMI (kg/m2)28 (10.10)23.97 (5.10)0.005
BMI percentile98th (6)98th (11)0.80
BMI -score2.08 (0.79)2 (0.71)0.79
WtHR61.17 (10.85)59 (5.23)0.30
Total cholesterol (mg/dL)160 (38)167 (53)0.93
LDL cholesterol (mg/dL)99 (33)107.5 (46)0.73
HDL cholesterol (mg/dL)35 (8)48 (15)<0.001
Triglyceride (mg/dL)157 (91)70 (47)<0.001
Non-HDL cholesterol (mg/dL)128 (34)114 (46)0.13
Triglyceride/HDL cholesterol ratio4.14 (3.31)1.65 (1.11)<0.001
C-reactive protein (mg/dL)0.39 (0.54)0.38 (1.40)0.98
Fasting glucose (mg/dL)89 (8)88 (12)0.71
ASAT (UI/L)23 (9)23 (7)0.96
ALAT (UI/L)31 (30)26 (12)0.07
Alkaline phosphatase (UI/L)232.5 (146)243 (111)0.53
Uric acid (mg/dL)5.20 (2.2)4.30 (2.2)0.16
Obese (, %)21 (84%)38 (88.4%)0.71
Insulin (mU/L)14.81 (13.05)7.75 (9.89)0.083
HOMA-IR3.15 (2.45)1.69 (2.15)0.085
Hypertension (%)18 (72%)14 (32.6%)0.002
Systolic blood pressure percentile90th (49)50th (40)0.026
Diastolic blood pressure percentile90th (45)50th (40)0.040
Endocan (ng/mL)2.04 (1.17)3.06 (2.03)0.003
Lumican (ng/mL)14.29 (7.68)11.40 (4.81)0.06

Data are presented as median (interquartile range). BMI: body mass index; WtHR: waist to height ratio; ALAT: alanine aminotransferase; ASAT: aspartate aminotransferase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; HOMA-IR: Homeostatic Model Assessment of Insulin Resistance. values were computed with Mann-Whitney tests for continuous variables and Fisher exact test for nominal variables.